| Literature DB >> 34533045 |
Rui Zhao1, Zhao Wang2, Fangfang Cao1, Jian Song1, Shuya Fan1, Juntao Qiu1, Xiaohan Fan2, Cuntao Yu1.
Abstract
Background It is well established that postoperative atrial fibrillation (POAF) is associated with adverse postoperative outcomes after major cardiac operations. The purpose of this study was to investigate the incidence of new-onset POAF after successful total arch repair surgery and the association between POAF and in-hospital mortality. Methods and Results All consecutive patients undergoing total arch repair from September 2012 to December 2019 in Fuwai hospital were enrolled (n=1280). Patients diagnosed with preoperative atrial fibrillation were excluded. POAF was diagnosed as the new-onset atrial fibrillation or flutter for more than 5 minutes based on continuous electrocardiogram monitoring. A logistic regression model was used to determine predictors of in-hospital mortality. Multivariable adjustment, inverse probability of treatment weighting, and propensity score matching were used to adjust for confounders. POAF was diagnosed in 32.3% (411/1271) of this cohort population. The occurrence of new-onset POAF was associated with age (odds ratio [OR], 1.05; 95% CI, 1.04-1.06; P<0.001), male sex (OR, 0.72; 95% CI, 0.52-0.98; P=0.035), and surgery duration (OR, 1.2; 95% CI, 1.12-1.28; P<0.001). The in-hospital mortality was significantly higher in patients with POAF than those without POAF (10.7% versus 2.4%, P<0.001). Inverse probability of treatment weighting and propensity score matching analyses confirmed the results. The increased in-hospital mortality in POAF group still existed among subgroup analysis based on different age, sex, hypertension, smoking, and hypokalemia, combined with cardiac surgery, and deep hypothermic circulatory arrest. Conclusions More careful attention should be given to POAF after total arch repair surgery. The incidence of POAF after total arch repair surgery was 32.3% and associated with increased in-hospital mortality. The elderly female patient who experienced longer operation duration was at highest risk for POAF.Entities:
Keywords: aortic disease; aortic dissection; arrhythmia; atrial fibrillation
Mesh:
Year: 2021 PMID: 34533045 PMCID: PMC8649499 DOI: 10.1161/JAHA.121.021980
Source DB: PubMed Journal: J Am Heart Assoc ISSN: 2047-9980 Impact factor: 5.501
Figure 1Study design: summary of inclusion and exclusion criteria.
AF indicates atrial fibrillation; IPTW, inverse probability of treatment weighting; POAF, postoperative atrial fibrillation; PSM, propensity score matching; and TAR, total arch repair.
Characteristics of 1271 Patients Undergoing TAR Surgery from 2012 to 2019
| Variable | Non‐POAF | POAF |
|
|---|---|---|---|
| No. of patients | n=860 | n=411 | |
| Age, y | 47.97±11.15 | 53.66±10.86 | <0.001 |
| Male sex, n (%) | 658 (76.5) | 279 (67.9) | 0.001 |
| Body mass index, kg/m2 | 25.84 (23.40–28.40) | 25.97 (23.69–28.08) | 0.474 |
| Marfan syndrome, n (%) | 37 (4.3) | 5 (1.2) | 0.007 |
| Aortic family history, n (%) | 24 (2.8) | 7 (1.7) | 0.326 |
| Hypertension, n (%) | 679 (79.0) | 341 (83.0) | 0.108 |
| Hyperlipidemia, n (%) | 208 (24.2) | 111 (27.0) | 0.31 |
| Diabetes mellitus, n (%) | 31 (3.6) | 13 (3.2) | 0.811 |
| Chronic obstructive pulmonary disease, n (%) | 7 (0.8) | 4 (1.0) | >.99 |
| Chronic kidney disease, n (%) | 20 (2.3) | 17 (4.1) | 0.106 |
| Current smoker, n (%) | 357 (41.5) | 165 (40.1) | 0.688 |
| Hemoglobin, g/L | 136.00 (123.75–147.00) | 133.00 (120.00–145.00) | 0.009 |
| White blood cell, ×109 | 11.03 (8.48–13.62) | 10.88 (8.57–13.82) | 0.968 |
| Platelet, ×109 | 181.00 (147.00–228.00) | 167.00 (137.00–210.00) | <0.001 |
| Left ventricular ejection fraction, % | 60.00 (59.00–62.00) | 60.00 (58.00–62.00) | 0.798 |
| Hypokalemia, n (%) | 114 (13.3) | 49 (11.9) | 0.565 |
| Left atrial diameter, mm | 35.00 (32.00–38.00) | 35.00 (32.00–38.00) | 0.625 |
| Combined with cardiac surgery, n (%) | 316 (36.7) | 164 (39.9) | 0.306 |
| DHCA, n (%) | 746 (86.7) | 334 (81.3) | 0.013 |
| Surgery time, h | 6.25 (5.42–7.50) | 6.75 (5.82–8.03) | <0.001 |
| Cardiopulmonary bypass time, min | 168.00 (140.00–200.00) | 186.00 (143.50–227.00) | <0.001 |
| Cross‐clamp time, min | 97.00 (79.00–119.00) | 104.00 (81.00–131.00) | 0.002 |
| DHCA time, min | 18.00 (13.00–22.00) | 18.00 (10.00–23.00) | 0.751 |
| Minimum operating temperature, °C | 23.92 (19.40–25.51) | 24.08 (18.90–26.24) | 0.771 |
| Euro‐score | 7.00 (5.00–8.00) | 7.00 (4.00–8.00) | 0.128 |
DHCA indicates deep hypothermic circulatory arrest; POAF, postoperative atrial fibrillation; and TAR, total arch repair.
Univariate and Multivariate Risk Factors for AF
| Risk factor | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|
| OR | 95% CI |
| OR | 95% CI |
| |
| Age, y | 1.05 | 1.04–1.06 | <0.001 | 1.05 | 1.05–1.03 | <0.001 |
| Male sex | 0.65 | 0.5–0.84 | 0.001 | 0.72 | 0.52–0.98 | 0.035 |
| Marfan syndrome | 0.27 | 0.11–0.70 | 0.007 | 0.5 | 0.19–1.31 | 0.181 |
| Hemoglobin, g/L | 0.99 | 0.99–1.00 | 0.012 | 1.00 | 0.99–1.01 | 0.716 |
| Platelet, ×109 | 1.0 | 1.0–1.0 | 0.004 | 1 | 1–1.00 | 0.131 |
| Deep hypothermic circulatory arrest | 0.66 | 0.48–0.91 | 0.011 | 1.28 | 0.86–1.91 | 0.088 |
| Surgery time, h | 1.18 | 1.11–1.26 | <0.001 | 1.17 | 1.12–1.28 | <0.001 |
| Cardiopulmonary bypass time, min | 1.00 | 1.00–1.01 | <0.001 | 1.00 | 1.00–1.00 | 0.259 |
| Cross clamp time, min | 1.00 | 1.00–1.01 | 0.003 | 1.00 | 1.00–1.00 | 0.319 |
AF indicates atrial fibrillation; and OR, odds ratio.
Clinical Outcomes and Postoperative Complications
| Variable | No‐POAF | POAF |
|
|---|---|---|---|
| No. of patients | n=860 | n=411 | |
| In‐hospital mortality, n (%) | 21 (2.4) | 44 (10.7) | <0.001 |
| Expenses, yuan | 168704.60 (147621.22–225067.13) | 230767.92 (177005.94–310158.41) | <0.001 |
| Hospital length of stay, d | 12 (9–17) | 14 (11–20) | <0.001 |
| Intensive care unit time, h | 72.00 (48.00–120.00) | 144.00 (96.00–264.00) | <0.001 |
| Mechanical ventilation time, h | 16.23 (9.54–33.96) | 34.22 (12.71–91.47) | <0.001 |
| Perioperative stroke, n (%) | 27 (3.1) | 27 (6.6) | 0.007 |
| Sepsis, n (%) | 4 (0.5) | 16 (3.9) | <0.001 |
| Pulmonary infection, n (%) | 31 (3.6) | 43 (10.5) | <0.001 |
| Acute kidney injury, n (%) | 201 (23.4) | 186 (45.3) | <0.001 |
| Acute hepatic failure, n (%) | 10 (1.2) | 32 (7.8) | <0.001 |
| Re‐exploration, n (%) | 21 (2.4) | 31 (7.5) | <0.001 |
POAF indicates postoperative atrial fibrillation.
Summary of Clinical Outcomes and OR for POAF Group
| Type analysis | Sample size | In‐hospital mortality | |||
|---|---|---|---|---|---|
| No‐POAF | POAF | No. (%) | OR (95% CI) |
| |
| Unadjusted | 860 | 411 | 21 vs 44 (2.4% vs 10.7%) | 4.79 (2.81–8.17) | <0.001 |
| Matched | 411 | 411 | 12 vs 44 (2.9% vs 10.7%) | 1.08 (1.05–1.19) | <0.001 |
| Weighted | 864.62 | 401.75 | 30.9 vs 35.1 (3.6% vs 8.7%) | 1.04 (1.03–1.08) | <0.001 |
| Multivariable | 860 | 411 | 21 vs 44 (2.4% vs 10.7%) | 2.53 (1.39–4.70) | 0.003 |
OR indicates odds ratio; and POAF, postoperative atrial fibrillation.
Figure 2Covariate balance in the study cohort.
BMI indicates body mass index; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; CPB, cardiopulmonary bypass; DHCA, deep hypothermic circulatory arrest; LVEF, left ventricular ejection fraction; SMD, standardized mean difference; and WBC, white blood cell.
Figure 3In‐hospital mortality of POAF in subgroup analysis.
The pooled odds ratio (OR) presented graphically as a purple diamond, where the center of the diamond is the overall estimate and the width of the diamond is the overall confidence. The OR of each subgroup is presented in green squares and 95% CI is presented by a horizontal black line. POAF indicates postoperative atrial fibrillation.